Author

Ezra Tai

Observed names: Ezra H.L. Tai, Tai, Ezra

Institution: ChemoCentryx (United States)

Observed institution: ChemoCentryx (United States)

ORCID: 0009-0008-8210-460X

Observed ORCID: 0009-0008-8210-460X

OpenAlex ID: A5046917072

2′-Deoxy-4′-azido Nucleoside Analogs Are Highly Potent Inhibitors of Hepatitis C Virus Replication Despite the Lack of 2′-α-Hydroxyl Groups

2007 · Klaus Klumpp, Genadiy Kalayanov, et al. · Journal of Biological Chemistry · 93

Arbaclofen Placarbil, a Novel R-Baclofen Prodrug: Improved Absorption, Distribution, Metabolism, and Elimination Properties Compared with R-Baclofen

2009 · Ritu Lal, Juthamas Sukbuntherng, et al. · Journal of Pharmacology and Experimental Therapeutics · 85

A phase I thorough QT / QTc study evaluating therapeutic and supratherapeutic doses of avacopan in healthy participants

2024 · Shichang Miao, Peter Staehr, et al. · Clinical and Translational Science · 7

Favorable Metabolism and Pharmacokinetics of Formulations of XP23829, a Novel Fumaric Acid Ester, in Healthy Subjects (P05.189)

2013 · Dmitri Lissin, Wendy Luo, et al. · Neurology · 2

Mass Balance and Metabolic Profiling of Avacopan, a Selective C5a Receptor 1 Antagonist, in Healthy Humans

2025 · Yang Song, Shichang Miao, et al. · Current Drug Metabolism · 1

Steady State Pharmacokinetics of Formulations of XP23829, a Novel Prodrug of Monomethyl Fumarate (MMF), in Healthy Subjects (P1.188)

2014 · Dmitri Lissin, Wendy Luo, et al. · Neurology · 1

CCDC 671179: Experimental Crystal Structure Determination

2022 · Klumpp, Klaus, Kalayanov, Genadiy, et al. · The Cambridge Structural Database

Abstract 4147: CCX559, an orally administered small molecule PD-L1 inhibitor for the treatment of solid tumors

2022 · Kathleen M. Sullivan, Shichang Miao, et al. · Cancer Research

Works count: 8

Citation count: 189

H-index: 3

I10-index: 2